Clinical Trials Results - National Cancer Institute

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -6 of 6 Show results per page	View Search Criteria \| Help With Results

Last Modified: 10/1/2001 First Published: 10/1/1999


1.		Phase I/II Study of Radioimmunotherapy with Yttrium Y 90 Monoclonal Antibody MN-14 With or Without Doxorubicin Plus Peripheral Blood Stem Cell Rescue in Patients with Medullary Thyroid Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				16 to 80				Other				CMMI-C-040A-98 CMMI-FDR001555, NCI-V99-1564, NCT00004048

Last Modified: 5/1/2002 First Published: 10/1/1999


2.		Phase I/II Study of High-Dose Radioimmunotherapy With Yttrium Y 90 Monoclonal Antibody MN-14 Plus Peripheral Blood Stem Cell Rescue in Patients With Stage IV Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				18 and over				NCI				CMMI-C-041A-98 NCI-H99-0039, NCI-V99-1568, NCT00004085

First Published: 1/1/2000


3.		Phase I/II Study of High Dose Radioimmunotherapy with Yttrium Y 90 Monoclonal Antibody MN-14 Plus Autologous Peripheral Blood Stem Cell Rescue in Patients with Advanced Ovarian Epithelial Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				18 to 80				NCI				CMMI-C-039A-98 NCI-H99-0044, NCI-V99-1570, NCT00004177

Last Modified: 4/1/2002 First Published: 11/1/1999


4.		Phase I/II Study of High Dose Radioimmunotherapy with Yttrium Y 90 Monoclonal Antibody MN-14 Plus Autologous Peripheral Blood Stem Cell Rescue in Patients with Metastatic or Recurrent Colorectal Cancer or Pancreatic Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				18 to 80				NCI				CMMI-C-033-98 NCI-H99-0042, NCI-V99-1571, NCT00004087

Last Modified: 10/1/2001 First Published: 11/1/2000


5.		Phase I Study of Yttrium Y 90 Anti-CEA Monoclonal Antibody MN-14 in Patients With Relapsed or Refractory Non-Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				18 and over				NCI				CMMI-C-047A-99 NCI-H00-0063, NCT00006458

Last Modified: 4/21/2003 First Published: 10/1/2000


6.		Phase I Study of Yttrium Y 90 Anti-CEA Monoclonal Antibody MN-14 in Patients With Relapsed or Refractory Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				18 and over				NCI				CMMI-C-057A-99 NCI-H00-0064, NCT00006347

Select All on One Page